COMP <GO>
PRTA vs CRMD // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Prothena Corporation plc (NASDAQ) VS. CorMedix Inc. (NASDAQ) • 15-METRIC TALLY: PRTA 1
— CRMD 7
■ METRIC PARITY
LAST: $8.29 (-2.12%) • MKT CAP: $434.8M
options-implied-move
—
LAST: $5.39 (-5.36%) • MKT CAP: $443.9M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRTA VS. CRMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRTA | CRMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 45.50% | -80.50 | CRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 3.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 48.20% | -108.20 | CRMD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 52.30% | -112.30 | CRMD | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 180.00% | -245.00 | CRMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 1.81 | -1.61 | CRMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 8/9 | -6.00 | CRMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.3 | 37.1 | +11.20 | PRTA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $434.8M | $443.9M | -$9.1M | CRMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRTA REV | CRMD REV | PRTA GROSS % | CRMD GROSS % | PRTA FCF | CRMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.7M | $311.7M | — | 88.5% | -$163.6M | $172.8M |
| FY 2024 | $135.2M | $43.5M | — | 92.7% | -$150.1M | -$50.7M |
| FY 2023 | $91.4M | $137.1M | — | — | -$133.9M | -$38.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRTA // BETA —
CRMD // BETA —